Aridis Pharmaceuticals, Inc. Stock price
Equities
ARDS
US0403341045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 USD | +4.35% | +5.41% | +11.27% |
Financials (USD)
Sales 2023 * | 21.4M | Sales 2024 * | 7.6M | Capitalization | 3.74M |
---|---|---|---|---|---|
Net income 2023 * | 4M | Net income 2024 * | -4M | EV / Sales 2023 * | 0.17 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.49 x |
P/E ratio 2023 * |
1.11
x | P/E ratio 2024 * |
-0.87
x | Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.2% |
1 day | +4.35% | ||
1 week | +5.41% | ||
Current month | +1.04% | ||
1 month | +1.30% | ||
3 months | +14.71% | ||
6 months | -17.37% | ||
Current year | +11.27% |
Managers | Title | Age | Since |
---|---|---|---|
Vu Truong
CEO | Chief Executive Officer | 60 | 02-12-31 |
Eric Patzer
FOU | Founder | 75 | 02-12-31 |
Tamara Allen
DFI | Director of Finance/CFO | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Hamilton
BRD | Director/Board Member | 79 | 15-03-31 |
Eric Patzer
FOU | Founder | 75 | 02-12-31 |
Vu Truong
CEO | Chief Executive Officer | 60 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.078 | +4.35% | 18,884 |
24-03-27 | 0.0748 | +0.88% | 35,280 |
24-03-26 | 0.0741 | -4.88% | 5,811 |
24-03-25 | 0.0779 | -0.13% | 43,293 |
24-03-22 | 0.078 | +5.41% | 16,538 |
Delayed Quote OTC Markets, March 28, 2024 at 02:49 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.27% | 3.74M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |